Impact of Acute Kidney Injury on Long-Term Mortality after Nonmyeloablative Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 3, 2008, Pages 309-315

  Parikh, Chirag R ^a   Yarlagadda, Sri G ^a   Storer, Barry ^b   Sorror, Mohamed ^b   Storb, Rainer ^b   Sandmaier, Brenda ^b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Bone marrow transplant; Prognosis; Renal dysfunction

Indexed keywords

CREATININE; CYCLOSPORIN; FLUDARABINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION TEST; KIDNEY INJURY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PERTHES DISEASE; PROGNOSIS; RETROSPECTIVE STUDY; WHOLE BODY RADIATION;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 38949161079     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.12.492     Document Type: Article

References (29)

1. Ringden O., Horowitz M.M., Gale R.P., et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 270 (1993) 57-60
2. Thomas E., Storb R., Clift R.A., et al. Bone-marrow transplantation (first of two parts). N Engl J Med 292 (1975) 832-843
3. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 (2001) 3390-3400
4. Niederwieser D., Maris M., Shizuru J.A., et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101 (2003) 1620-1629
5. Zager R.A. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46 (1994) 1443-1458
6. Zager R.A., O'Quigley J., Zager B.K., et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13 (1989) 210-216
7. Parikh C.R., McSweeney P.A., Korular D., et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62 (2002) 566-573
8. Parikh C.R., Sandmaier B.M., Storb R.F., et al. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol 15 (2004) 1868-1876
9. Weiss A.S., Sandmaier B.M., Storer B., Storb R., McSweeney P.A., and Parikh C.R. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 6 (2006) 89-94
10. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
11. Bagshaw S.M., Laupland K.B., Doig C.J., et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 9 (2005) R700-R709
12. Loef B.G., Epema A.H., Smilde T.D., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16 (2005) 195-200
13. Parikh C.R., McSweeney P., and Schrier R.W. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 67 (2005) 1999-2005
14. Parikh C.R., Schrier R.W., Storer B., et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 45 (2005) 502-509
15. Manjunath G., Sarnak M.J., and Levey A.S. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens 10 (2001) 785-792
16. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919
17. Sorror M.L., Maris M.B., Storer B., et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood 104 (2004) 961-968
18. Maris M.B., Niederwieser D., Sandmaier B.M., et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 102 (2003) 2021-2030
19. Boeckh M. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy. Transpl Infect Dis 1 (1999) 165-178
20. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15 (1995) 825-828
21. Georges G.E., Maris M., Sandmaier B.M., et al. Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. Int J Hematol 76 Suppl 1 (2002) 184-189
22. Amado R.G., and Schiller G.J. Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies. Semin Oncol 27 Suppl 5 (2000) 82-89
23. Burt R.K., Traynor A., Statkute L., et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295 (2006) 527-535
24. Tonelli M., Wiebe N., Culleton B., et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17 (2006) 2034-2047
25. Sullivan K.M., Witherspoon R.P., Storb R., et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72 (1988) 555-561
26. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
27. Kelly K.J. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 14 (2003) 1549-1558
28. Goldberg A., Hammerman H., Petcherski S., et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 150 (2005) 330-337
29. Jose P., Skali H., Anavekar N., et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 17 (2006) 2886-2891